Seneca Biopharm Inc (SNCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SNCA | AMGN | BMY | GILD | VRTX |
| Company | Seneca Biopharm Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 9.9000 | 267.54 | 48.44 | 67.35 | 394.94 |
| High | 10.0278 | 268.77 | 48.55 | 67.55 | 398.11 |
| Low | 9.7200 | 263.39 | 47.70 | 66.89 | 392.03 |
| Last | 9.9600 | 264.07 | 47.84 | 66.93 | 393.10 |
| Change | -0.1200 | -1.57 | -0.42 | -0.38 | -1.07 |
| % Change | -1.19% | -0.59% | -0.87% | -0.56% | -0.27% |
| Volume | 194,116 | 2,175,100 | 11,763,000 | 5,287,700 | 881,000 |
| 20-Day Average Volume | 1,882,520 | 2,225,995 | 11,395,495 | 6,258,365 | 901,850 |
| Previous Close | 10.0800 | 265.64 | 48.26 | 67.31 | 394.17 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.6135 | 273.48 | 51.17 | 70.61 | 407.52 |
| 20-Day Raw Stochastic | 58.18% | 2.72% | 2.07% | 0.54% | 3.63% |
| 20-Day Relative Strength | 52.73% | 37.63% | 34.65% | 29.70% | 36.51% |
| Weighted Alpha | +97.27 | +4.99 | -31.08 | -24.05 | +15.47 |
| Today's Opinion | 96% Buy | 56% Sell | 56% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 96% Buy | 40% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 88% Buy | 8% Sell | 24% Sell | 88% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.16% since 04/20/21 | -0.89% since 04/10/24 | -4.87% since 04/10/24 | -1.75% since 04/10/24 | -1.13% since 04/10/24 |
| Low | 1.4501 on 04/21/21 | 263.39 on 04/17/24 | 47.70 on 04/17/24 | 66.89 on 04/17/24 | 392.03 on 04/17/24 |
| High | 1.8800 on 04/26/21 | 273.00 on 04/11/24 | 50.58 on 04/11/24 | 69.03 on 04/11/24 | 404.69 on 04/11/24 |
| 1-Month | |||||
| %Chg | +7.10% since 03/26/21 | -1.79% since 03/15/24 | -8.60% since 03/15/24 | -9.17% since 03/15/24 | -3.58% since 03/15/24 |
| Low | 1.3400 on 04/16/21 | 263.39 on 04/17/24 | 47.70 on 04/17/24 | 66.89 on 04/17/24 | 392.03 on 04/17/24 |
| High | 1.8900 on 04/06/21 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +22.96% since 01/27/21 | -13.16% since 01/17/24 | -4.28% since 01/17/24 | -22.61% since 01/17/24 | -9.37% since 01/17/24 |
| Low | 1.0301 on 03/04/21 | 263.39 on 04/17/24 | 47.58 on 02/06/24 | 66.89 on 04/17/24 | 392.03 on 04/17/24 |
| High | 2.6700 on 03/22/21 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +167.74% since 10/27/20 | -7.15% since 10/17/23 | -16.61% since 10/17/23 | -16.84% since 10/17/23 | +5.25% since 10/17/23 |
| Low | 0.5394 on 11/05/20 | 249.70 on 10/31/23 | 47.58 on 02/06/24 | 66.89 on 04/17/24 | 341.90 on 11/16/23 |
| High | 2.6700 on 03/22/21 | 329.72 on 02/05/24 | 57.59 on 10/18/23 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 28,711 | 141,520,144 | 96,960,152 | 83,333,008 | 101,600,240 |
| Shares Outstanding, K | 17,296 | 535,919 | 2,026,759 | 1,245,077 | 258,459 |
| Annual Sales | 10,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -16,270,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 2,500 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -4,418,839 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 1.88 | 0.58 | 0.39 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/21/21 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.24 | 6.43 | 10.02 | 29.33 |